z-logo
open-access-imgOpen Access
The Development of Novel Apurinic/Aprymidinic Endonuclease/Redox-factor 1 Inhibitors for the Treatment of Human Melanoma
Author(s) -
Bella Sharifi
Publication year - 2019
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.36837/chapman.000103
Subject(s) - ap site , dna (apurinic or apyrimidinic site) lyase , endonuclease , transcription factor , dna , dna repair , dna damage , ap endonuclease , cancer research , biology , chemistry , microbiology and biotechnology , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom